Oklahoma Medical Research Foundation (OMRF) has set its sights on revolutionizing our understanding of lupus, a complex autoimmune disease that affects millions worldwide. With a prestigious $6.4 million grant, OMRF, led by Dr. Judith James, is embarking on a mission to detect lupus earlier and thwart its potentially devastating impact. 

UNVEILING THE COMPLEXITIES OF LUPUS 

Lupus, a disease in which the immune system mistakenly targets the body's own tissues, can lead to damage in various organs, including joints, skin, kidneys, heart and lungs. It is particularly concerning for women of childbearing age and has remained a medical enigma due to its elusive origins and diverse manifestations. 

Dr. James and her team at OMRF are pioneering the Autoimmune Drivers and Protectants (ADAPTS) study, which seeks to identify individuals at high risk of developing systemic lupus erythematosus (SLE), the most common form of lupus. These high-risk individuals possess either a family history of the disease or have tested positive for specific autoantibodies associated with lupus. 

"Some people have blood markers for lupus but never get sick," explains Dr. James, a member of the National Academy of Medicine. "Others have the markers and develop some symptoms but never get the full-blown disease, while in others, it ravages the body. We want to better understand why and ideally how to prevent the transitions." 

COLLABORATIVE APPROACH 

This groundbreaking study aims to uncover the factors that drive the progression from benign autoimmunity to clinical autoimmunity, potentially paving the way for personalized preventive therapies. By collaborating with renowned experts from Vanderbilt University and New York University, Dr. James and her team are assembling a multi-faceted approach to tackle the complexity of lupus. 

Dr. Jill Buyon, director of the NYU Langone Health Lupus Center, is also contributing to the research by analyzing samples from study volunteers who, despite being asymptomatic, have autoantibodies linked to lupus. In some cases, these autoantibodies have resulted in heart damage in their infants.  

"If we can unlock the secrets of what makes someone progress from benign autoimmunity to clinical autoimmunity, that would be revolutionary. Then we could tell a woman, 'You have these factors, so we might want to put you on preventive therapy,'" explained Dr. Buyon. 

To achieve these ambitious goals, Dr. James and her team will analyze thousands of patient samples, delving into the genetic and environmental factors that influence the development of lupus. This research could potentially lead to identifying protective mechanisms against the disease, offering hope for improved preventive strategies. 

VOLUNTEERS NEEDED 

OMRF needs people to participate in the study. They need volunteers who are at high risk of developing lupus due to their family history or positive autoantibody tests to participate in this vital research. Those interested in volunteering for the study are asked to call 405-271-7221.  

PIONEERING THE PATH FORWARD IN LUPUS RESEARCH 

The significance of this study is underscored by the funding it has received, a grant issued by the National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health. With this funding and the collaborative efforts of distinguished researchers, the ADAPTS study can revolutionize our understanding of lupus and pave the way for preventive interventions that could transform lives. 

This story originally ran on VeloCityOKC.com.